← Eichor
Study identifier: NCT05735691 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

Condition: Multiple Sclerosis  ·  Sponsor: Marquette University

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to improve walking speed, balance, and walking in the community for people with multiple sclerosis. This trial involves intense exercise combined with walking on a shaky treadmill. Walking on a shaky treadmill helps to practice balance and intense exercise promotes the ability to walk faster and farther. In this study, participants will train with a combination of high or low intensity, and with a stable or shaky treadmill. Walking speed and endurance, balance while walking and the number of steps taken in the community will be measured before, half way through the training (15 sessions), after training (30 sessions) and six months after training.

This description comes directly from the study's public registry record.

Talk to the study team

Brian D Schmit, PhD  ·  4142886125  ·  brian.schmit@marquette.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Rehabilitation Hospital of IndianaIndianapolis, Indiana, United StatesRecruiting
Marquette UniversityMilwaukee, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05735691